Evaluation of a re-engineered device for penile vibratory stimulation in men with spinal cord injury.

Autor: Ibrahim E; Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA. eibrahim@miami.edu., Jensen CFS; Department of Urology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark., Sunara I; Department of Neurobiology, Care Science and Society, Spinalis Spinal Cord Injury Unit, Karolinska Institute, Stockholm, Sweden., Khodamoradi K; Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA., Aballa TC; Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA., Elliott S; Departments of Psychiatry and Urological Sciences, University of British Columbia, Vancouver, BC, Canada., Sonksen J; Department of Urology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark., Ohl DA; Department of Urology, University of Michigan, Ann Arbor, MI, USA., Hultling C; Department of Neurobiology, Care Science and Society, Spinalis Spinal Cord Injury Unit, Karolinska Institute, Stockholm, Sweden., Lynne CM; Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA., Seager SWJ; National Rehabilitation Hospital, Washington, DC, USA., Brackett NL; The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL, USA.
Jazyk: angličtina
Zdroj: Spinal cord [Spinal Cord] 2021 Feb; Vol. 59 (2), pp. 151-158. Date of Electronic Publication: 2020 Jul 14.
DOI: 10.1038/s41393-020-0515-6
Abstrakt: Study Design: Cohort study OBJECTIVES: The purpose of this study was to evaluate the performance of a re-engineered device (Ferticare 2.0), which is replacing the previous standard (Ferticare 1.0) for penile vibratory stimulation in men with spinal cord injury. Most men with spinal cord injury are anejaculatory, requiring medical assistance to obtain their semen. Penile vibratory stimulation is generally recognized as the standard of care for semen retrieval in these anejaculatory men.
Setting: Major Research University in Miami, Florida, USA.
Methods: The Ferticare 2.0 device was applied to 15 men with spinal cord injury in a three-step protocol simulating normal use. Step 1: one device (2.5 mm amplitude, 100 Hz) was applied to the glans penis for 2 min. Step 2: If no ejaculation occurred, the amplitude was increased to 4.0 mm (100 Hz) and the device similarly applied. Step 3: If no ejaculation occurred, two devices, each 2.5 mm and 100 Hz were applied to the dorsum and frenulum of the glans penis. Participants at risk for autonomic dysreflexia were pretreated with sublingual nifedipine (20 mg), 15 min prior to stimulation. Blood pressure and other symptoms of autonomic dysreflexia were monitored. Participants answered a questionnaire about their experience with the device.
Results: Thirteen of 15 participants ejaculated with the device. No adverse events occurred. All participants commented they would recommend the device to other men with spinal cord injury.
Conclusions: A re-engineered device, the Ferticare 2.0, is safe and effective for inducing ejaculation in men with spinal cord injury.
Databáze: MEDLINE
Externí odkaz: